Clinical Orofacial Characteristics Associated With Risk of First-Onset TMD: The OPPERA Prospective Cohort Study
Key words
Cited by (0)
Publication of this supplement was made possible with support of the National Institutes of Health grant U01DE017018 and P01NS045685. The OPPERA program also acknowledges resources specifically provided for this project by the participating institutions: Battelle Memorial Institute; University at Buffalo; University of Florida; University of Maryland; University of North Carolina at Chapel Hill.
R.B.F. and G.D.S. are consultants and equity stock holders, and W.M. and L.D. are cofounders and equity stock holders in Algynomics, Inc, a company providing research services in personalized pain medication and diagnostics. Other authors declare no conflicts of interest.
Portions of these data were presented at the 2012 Annual Scientific Meeting of the International Association for Dental Research in Iguaçu Falls, Brazil.